ONCOLOGY 期刊简介
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
尽管需要将实验室和临床癌症研究紧密联系在一起，但基本水平的观察结果通常仍从医学应用中删除。该期刊致力于加速将实验结果转化为临床，并再次转化为实验室进行进一步研究。这项工作的根本目的是提高癌症的临床相关知识，并改善恶性疾病的预防，诊断和治疗的结果。该杂志发表了来自世界各地癌症项目的重要临床研究，以及重要的转化实验室发现，迷你评论 (邀请和提交) 以及对肿瘤学领域不断发展和有争议的主题的深入讨论。该杂志的一个独特之处是一个新的部分，重点是快速同行评审和随后发表的第一阶段和第二阶段临床癌症试验的简短报告，目的是确保高质量的临床癌症研究迅速进入公共领域，无论试验关于疗效或毒性的最终结论如何.
|
期刊ISSN
|
0030-2414 |
|
影响指数
|
2.906 |
|
最新CiteScore值
|
5.10 查看CiteScore评价数据 |
|
最新自引率
|
2.40% |
|
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
|
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址：https://www.deeredit.com/?type=ss2，资深审稿专家为您评估稿件质量，提供针对性改进建议，最终可助您极大提升目标期刊录用率 |
|
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
|
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
|
通讯地址
|
KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009 |
|
偏重的研究方向（学科）
|
医学-肿瘤学 |
|
出版周期
|
Bimonthly |
|
出版年份
|
1967 |
|
出版国家/地区
|
SWITZERLAND |
|
是否OA
|
No |
|
SCI期刊coverage
|
Science Citation Index Expanded（科学引文索引扩展） |
|
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
|
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)4区
否
|
|||||
|
最新的影响因子
|
2.906 | |||||
| 最新公布的期刊年发文量 |
|
|||||
| 总被引频次 | 92 | |||||
| 影响因子趋势图 |
近年的影响因子趋势图（整体平稳趋势）
|
|||||
2022年预警名单预测最新
|
最新CiteScore值
|
5.10
|
||||||||||||||
| 年文章数 | 122 | ||||||||||||||
|
SJR
|
0.987 | ||||||||||||||
|
SNIP
|
0.919 | ||||||||||||||
|
CiteScore排名
|
|
||||||||||||||
| CiteScore趋势图 |
CiteScore趋势图
|
||||||||||||||
|
本刊同领域相关期刊
|
|
| 期刊名称 | IF值 |
| INTEGRATIVE CANCER THERAPIES | 3.246 |
| Hormones & Cancer | 3.83 |
| ENDOCRINE-RELATED CANCER | 5.621 |
| Frontiers of Medicine | 4.546 |
| Molecular Medicine Reports | 2.922 |
| Molecular Therapy-Oncolytics | 7.128 |
| American Journal of Translational Research | 4.019 |
| BREAST | 4.336 |
| Breast Care | 2.831 |
|
本刊同分区等级的相关期刊
|
|
| 期刊名称 | IF值 |
| INTEGRATIVE CANCER THERAPIES | 3.246 |
| Hormones & Cancer | 3.83 |
| Frontiers of Medicine | 4.546 |
| American Journal of Translational Research | 4.019 |
| BREAST | 4.336 |
| Journal of Gynecologic Oncology | 4.357 |
| OncoTargets and Therapy | 4.106 |
| BMC CANCER | 4.386 |
| CANCER JOURNAL | 3.326 |
| 分享者 | 点评内容 |
